Concepedia

Katherine Helming

KH

4

Publications

846

Citations

4

H-Index

2013

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Boston Children's Hospital

Novartis (United States)

Broad Institute

Harvard University

Katherine Helming is an author at Dana-Farber Cancer Institute specializing in gene expression, medicine, and chromatin structure.

Top concepts

Publications per year

2013–2014

4

Publications

4

ARID1B is a specific vulnerability in ARID1A-mutant cancers

Katherine Helming, Xiaofeng Wang, Boris G. Wilson et al. · Nature Medicine · 2014 · 418 citations · Full text

Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of <i>SMARCA4</i> (<i>BRG1</i>) Mutation

Boris G. Wilson, Katherine Helming, Xiaofeng Wang et al. · Molecular and Cellular Biology · 2014 · 224 citations · Full text

, , +21

Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters

Michael Tolstorukov, Courtney G. Sansam, Ping Lu et al. · Proceedings of the National Academy of Sciences · 2013 · 187 citations · Full text

, , +19

Deletion of AIF1 but not of YCA1/MCA1 protects Saccharomyces cerevisiae and Candida albicans cells from caspofungin-induced programmed cell death

Christopher R. Chin, Faith Donaghey, Katherine Helming et al. · Microbial Cell · 2014 · 17 citations · Full text

Rows per page

1–4 of 4